An Analysis of Breast Cancer Risk in Women With Single, Multiple, and Atypical Papilloma

Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA.
American Journal of Surgical Pathology (Impact Factor: 5.15). 06/2006; 30(6):665-72. DOI: 10.1097/00000478-200606000-00001
Source: PubMed


Breast papillomas may be single or multiple and associated with atypical ductal or lobular hyperplasias (ADH/ALH). The risk of breast carcinoma development in patients with papillomas, particularly those with multiple or atypical lesions, is incompletely defined. Fibrocystic lesions were histopathologically classified in a benign breast disease cohort of 9155 who underwent biopsy from 1967 to 1991, with papilloma assessment in 9108. Individuals with papillomas (N=480) were classified into 4 groups: single papilloma (SP, N=372), single papilloma with ADH or ALH (SP+A, N=54), multiple (>5) papillomas (MP, N=41), and multiple papillomas with ADH or ALH (MP+A, N=13). Those without papillomas were classified as nonproliferative (NP, N=6053), proliferative without atypia (PDWA, N=2308), and ADH/ALH [atypical hyperplasia (AH), N=267]. The relative risk of cancer development within our cohort was compared to that expected in the general population using standardized incidence ratios. The relative risk of breast cancer development associated with SP [2.04, 95% confidence interval (CI) 1.43-2.81] was greater than NP (1.28, 95% CI 1.16-1.42) but similar to PDWA (1.90, 95% CI 1.66-2.16). The risk associated with SP+A (5.11, 95% CI 2.64-8.92) was highly elevated but not substantively different than atypical hyperplasia (4.17, 95% CI 3.10-5.50). Patients with MP are at increased risk compared with PDWA or SP (3.01, 95% CI 1.10-6.55), particularly those with MP+A (7.01, 95% CI 1.91-17.97). There was a marginal increase in breast cancer risk (16%) among patients with proliferative disease if a papilloma was present, but this did not reach statistical significance (P=0.29). The observed frequency of ipsilateral (vs. contralateral) breast cancer development in papilloma subsets was not significantly different than other patient groups. We conclude that SP imparts a cancer risk similar to conventional proliferative fibrocystic change. The presence of papilloma in, or associated with, atypia does not modify the risk connotation of ADH/ALH overall. MP constitutes a proliferative breast disease subset having unique clinical and biologic behavior.

Download full-text


Available from: Vernon Shane Pankratz, Oct 03, 2015
227 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Il existe trois grandes situations induisant au moins un doublement du risque de cancer du sein, seuil à partir duquel des modifications de stratégies de dépistage ou de prévention seront discutées. Ce sont: les antécédents familiaux (mutation BRCA1 ou BRCA2 identifiée, histoire familiale significative sans mutation BRCA1/2 identifiée et autres syndromes génétiques exceptionnels identifiés: p53; Cowden), les facteurs personnels histologiques (les néoplasies mammaires, les lésions histologiques pré-invasives), la densité mammaire et l’exposition à une irradiation importante avant l’âge de 20-30 ans. Enfin, notons la fréquente combinaison de facteurs de risque individuels et de facteurs familiaux. Ces situations pour l’imagerie posent le double problème des moyens de détection et des modalités de surveillance.
    Cancer du sein, 12/2006: pages 51-71;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Papillary lesions comprise a wide spectrum of lesions in terms of their clinical presentation, morphologic appearance, malignant potential, and clinical behavior. Their defining feature is that of a fibrovascular stromal core lined by epithelial and myoepithelial cells, attached to the wall of the duct and extending into the duct lumen. Papillary lesions are often diagnostically challenging both on core biopsy and in excision specimens. Much of the difficulty arises from the many different terminologies that are used to describe the various entities that are included under the umbrella term of papillary lesions. Separation of papillary lesions into categories with a meaningful clinical outcome is most appropriate; however, there is a relative paucity of well-designed outcome studies with substantial cohort numbers to provide information in this regard. We use a pragmatic approach to the classification of papillary lesions in our practice, as we will outline in this review. We will also discuss controversies surrounding papillary lesions and focus on management of these lesions on core biopsy and in excision specimens.
    Advances in Anatomic Pathology 04/2007; 14(2):108-19. DOI:10.1097/PAP.0b013e318032508d · 3.23 Impact Factor
  • Journal of Surgical Education 07/2007; 64(4):234-6. DOI:10.1016/j.jsurg.2007.03.007 · 1.38 Impact Factor
Show more